Review: HIV-1 protease inhibitors for treatment of visceral leishmaniasis in HIV-co-infected individuals

Source: Lancet Infectious Diseases Area: News The Lancet Infectious Diseases has featured a review discussing the management of patients with visceral leishmaniasis, and who are co-infected with HIV. Specifically, the review discusses the following topics:   . Protease inhibitors in HIV therapy . Protease inhibitors and visceral leishmaniasis
Source: NeLM - News - Category: Drugs & Pharmacology Source Type: news